EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹5.00 Cr | ₹4.91 Cr | ₹5.24 Cr | ₹5.55 Cr | ₹5.45 Cr |
What is the latest Contingent Liabilities ratio of EVEREST ORGANICS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹5.00 Cr |
Mar2023 | ₹4.91 Cr |
Mar2022 | ₹5.24 Cr |
Mar2021 | ₹5.55 Cr |
Mar2020 | ₹5.45 Cr |
How is Contingent Liabilities of EVEREST ORGANICS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹5.00 Cr | 1.83 | |
Mar2023 | ₹4.91 Cr | -6.35 | |
Mar2022 | ₹5.24 Cr | -5.50 | |
Mar2021 | ₹5.55 Cr | 1.72 | |
Mar2020 | ₹5.45 Cr | - |
Compare Contingent Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹395.8 Cr | -1.4% | -1.4% | 185.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,348.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,840.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
CIPLA | ₹124,222.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,346.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,437.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -1.4% |
-1.4% |
185.4% |
SENSEX | -1.2% |
0.5% |
-1.8% |
You may also like the below Video Courses